Respiratory medicines

Bronchi, inflammation and obstruction

Asthma and COPD are different diseases that can involve some shared medicine families. Bronchodilators act on airway calibre, while inhaled corticosteroids concern inflammation. Beta-2 agonists and anticholinergics illustrate different bronchodilator mechanisms. Combinations may bring several functions into one presentation. That relationship does not mean every medicine has the same indications in asthma and COPD. Mechanism and authorised product context remain distinct when interpreting its role. The pharmaceutical family explains an aspect of action, whereas the complete medicinal presentation identifies the ingredients, formulation and documented clinical setting.

Cough and secretions

Cough is a reflex accompanying different situations. Dry and productive describe the presence of secretions rather than establishing a cause. Cough suppressants, mucolytics and expectorants have different functions. Some preparations combine several active components and therefore need interpretation through their full composition. The field is not the same as antibiotics: a respiratory symptom does not demonstrate a bacterial origin. Class terminology consequently helps separate pharmacological action from the situation described. It also explains why related everyday words can appear on products with different regulatory statuses or mechanisms.

Other pulmonary approaches

Lung surfactants, respiratory stimulants and molecular approaches to particular diseases demonstrate the breadth of respiratory medicine. Influencing alveolar properties, respiratory drive or a protein such as CFTR does not represent the same mechanism. The medicines concerned have specialised contexts and should not be described as variations of cough treatments. Medicinal gases form a further distinct field. Alveolar mechanics, respiratory drive and ion transport consequently describe different biological dimensions rather than one uniform pulmonary mechanism.

Aerosols, powders and nebulisation

A pressurised aerosol, powder inhaler and nebuliser solution use different designs for delivery of the preparation. Declared units can describe an amount per actuation, content per unit or a concentration according to the medicine. A powder and a solution do not have the same pharmaceutical structure. Spacers, masks and accessories fulfil equipment functions associated with selected systems, distinct from substance activity. Combining actives in one device does not remove their individual roles, such as bronchodilation and anti-inflammatory action. Formulation and device together explain presentation characteristics without making every inhaled preparation equivalent.

Frequently asked questions